Intravenous anti-D immunoglobulin in the treatment of resistant immune thrombocytopenic purpura in pregnancy.


Abstract

A 35-week pregnant 38-year-old woman presented with isolated thrombocytopenia (platelet count 4 x 10(9)/l). Investigations confirmed immune thrombocytopenic purpura, and she received treatment with prednisolone and intravenous immunoglobulins with no increment in the platelet count.

At 37 and 38 weeks of the pregnancy, she received two doses of WinRho (anti-D immunoglobulin) at 50 microg/kg. Five days later, with a platelet count of 46 x 10(9)/l, she had an uncomplicated normal vaginal delivery. WinRho is a useful adjunct to other first-line treatment modalities for immune thrombocytopenia in pregnancy.


Full Text

  • DOI - BJOG : an international journal of obstetrics and gynaecology (DOI)
  • Blackwell Publishing - full-text online (subscription/membership/fee required)
  • EBSCO - full-text online (subscription/membership/fee required)
  • Ingenta plc - full-text online (subscription/membership/fee required)
  • Ovid Technologies, Inc. - full-text online (subscription/membership/fee required)
  • Swets Information Services - full-text online (subscription/membership/fee required)

Subjects


Similar articles

Authors


Publication date

2007-03-23


Journal

BJOG
BJOG (1470-0328)

Journal topics


Language

Eng.


Copyright

BJOG : an international journal of obstetrics and gynaecology

Department of Obstetrics and Gynaecology, West Middlesex University Hospital, Middlesex, UK.


Release reference

BJOG. 2007 Apr;114(4):505-7



Related books


Español | English

© Galenicom 1999-2013